Bioharvest Sciences (BHST) Gains from Investment Securities (2023 - 2024)

Bioharvest Sciences' (BHST) quarterly Gains from Investment Securities came in at $3.4 million in Q4 2024, up 16.89% year-on-year from $2.9 million in Q1 2024, and up 1036.68% quarter-over-quarter from -$368000.0 in Q3 2024.

Bioharvest Sciences (BHST) Gains from Investment Securities (2023 - 2024) Analysis & Trends

Bioharvest Sciences' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $3.4 million for Q4 2024.

  • On a quarterly basis, Gains from Investment Securities rose 16.89% year-over-year to $3.4 million in Q4 2024; TTM through Dec 2024 was $3.5 million, a N/A change from a year earlier, with the FY2024 full-year figure at $408000.0, down 22.43% from the prior year.
  • Gains from Investment Securities improved to $3.4 million in Q4 2024 per BHST's latest filing, from -$368000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $3.4 million in Q4 2024 and bottomed at -$368000.0 in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Kraft Heinz 31.17 Bn 27.07 Bn 2.22 Bn
2 General Mills 19.83 Bn 19.37 Bn 1.60 Bn
3 Hormel Foods 14.37 Bn 13.51 Bn 518.51 Mn
4 Mccormick 13.66 Bn 13.33 Bn 778.20 Mn
5 Magnum Ice Cream 11.07 Bn 10.54 Bn -
6 Smithfield Foods 10.48 Bn 9.09 Bn 511.00 Mn
7 Darling Ingredients 9.59 Bn 9.48 Bn 404.92 Mn
8 Oatly Group AB 9.05 Bn 9.00 Bn 81.36 Mn
9 Lamb Weston Holdings 7.40 Bn 7.33 Bn 361.40 Mn
10 Bioharvest Sciences 37.25 Mn 14.22 Mn 5.23 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 3.45 Mn
Dec 31, 2024 3.45 Mn
Sep 30, 2024 -368,000.00
Sep 30, 2024 -368,000.00
Mar 31, 2024 408,000.00
Mar 31, 2024 408,000.00
Dec 31, 2023 2.95 Mn
Dec 31, 2023 2.95 Mn
Sep 30, 2023 -368,000.00
Sep 30, 2023 -368,000.00